Enlivex Therapeutics Ltd. — Investor Relations & Filings
Filings indexed
379
across all filing types
Latest filing
2026-05-28
Regulatory Filings
Country
US
United States of America
Listing
US
ENLV
Enlivex Therapeutics Ltd. is a clinical-stage company developing macrophage reprogramming immunotherapy. Its primary focus is the development of Allocetra™, a universal, off-the-shelf cell therapy designed to rebalance immune hyper-responses. The therapy aims to modulate macrophages as a therapeutic strategy against inflammatory diseases. Enlivex is evaluating Allocetra™ for multiple indications, including acute inflammatory conditions like sepsis and chronic inflammatory diseases such as osteoarthritis. The product offers flexible administration options, including systemic intravenous infusion and targeted local injections, and has been administered in clinical trials to over 250 patients with no reported drug-related serious adverse events.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-28 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-27 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-18 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-15 | English | |
| 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-21 | English | |
| 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47859677 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-28 | English | ||
| 47518294 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-27 | English | ||
| 46384758 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-18 | English | ||
| 46362365 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-15 | English | ||
| 34766214 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-21 | English | ||
| 33814097 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-04-08 | English | ||
| 33048678 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-26 | English | ||
| 33040031 | 20-F - Enlivex Ltd. (0001596812) (Filer) | 2026-03-25 | English | ||
| 33040001 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-25 | English | ||
| 33032354 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-24 | English | ||
| 33013111 | 6-K - Enlivex Ltd. (0001596812) (Filer) | 2026-03-23 | English | ||
| 33001982 | 424B3 - Enlivex Ltd. (0001596812) (Filer) | 2026-03-20 | English | ||
| 19423449 | 6-K - Enlivex Therapeutics Ltd. (0001596812) (Filer) | 2026-02-10 | English | ||
| 30804306 | 6-K Filing | 2026-02-05 | English | ||
| 30804284 | 6-K Filing | 2026-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
H. Lundbeck A
A global biopharmaceutical company developing therapies for…
|
HLUN | DK | Manufacturing |
|
HOB BIOTECH GROUP CORP.,LTD.
Develops and manufactures IVD products for allergy and auto…
|
688656 | CN | Manufacturing |
|
Hoechst Pakistan Limited
Pharmaceutical company manufacturing and trading medicines,…
|
HPL | PK | Manufacturing |
|
HONZ PHARMACEUTICAL CO., LTD.
Specializes in pediatric pharmaceuticals, chemical drugs, a…
|
300086 | CN | Manufacturing |
|
HOVID BERHAD
Global pharma company specializing in R&D, manufacturing, a…
|
— | MY | Manufacturing |
|
HUADONG MEDICINE CO.,LTD
Pharmaceutical firm focused on metabolic diseases, oncology…
|
000963 | CN | Manufacturing |
|
Huakang Biomedical Holdings Company Limited
Develops, manufactures, and sells IVD reagents, specializin…
|
8622 | HK | Manufacturing |
|
Hualan Biological Engineering Inc.
Biopharmaceutical firm specializing in blood products and v…
|
002007 | CN | Manufacturing |
|
Hualan Biological Vaccine Inc.
Researches and manufactures human vaccines for influenza an…
|
301207 | CN | Manufacturing |
|
Hua Medicine
Drug development company focused on novel therapies, specia…
|
2552 | HK | Manufacturing |
Enlivex Therapeutics Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34882/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34882 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34882 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34882 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34882}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Enlivex Therapeutics Ltd. (id: 34882)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.